PH 2 ADI-PEG 20 Acute Myeloid Leukemia

NCT01910012 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Polaris Group